One study investigated the immunogenicity of CP-induced apoptosis in ovarian cancer cells, the immunological aspects of ovarian cancer chemotherapy in patients, and the cytotoxic T lymphocyte (CTL) response of tumor antigens to CD8(+) T cells in the window phase [56]. This evidence concerns the gene CP and ovarian carcinoma.